Inventor · disambiguated record
Steven Highfill
Also filed as: HIGHFILL STEVEN · HIGHFILL STEVEN L
3 granted patents·2 pending applications·47 citations·filing 2009–2023
71Inventor score
Top patents by PatentIndex Score
5 records- 0196US10253086B2CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cellNOVARTIS AG·Filed 2016·Granted Apr 9, 2019·37 cites·35 claims
- 0294US11149076B2CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cellNOVARTIS AG·Filed 2019·Granted Oct 19, 2021·9 cites·32 claims
- 0389US12344657B2CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cellNOVARTIS AG·Filed 2021·Granted Jul 1, 2025·1 cites·27 claims
- 0480US2023374105A1Cd20 therapies, cd22 therapies, and combination therapies with a cd19 chimeric antigen receptor (car)-expressing cellNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0557US2013129686A1Reducing Inflammation Using Cell TherapyHIGHFILL STEVEN L·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven Highfill files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →